What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Stefano Pileri mostly deals with Lymphoma, Pathology, Internal medicine, Cancer research and Immunology.
His Lymphoma study combines topics in areas such as Peripheral T-cell lymphoma, Germinal center and Survival analysis.
His work carried out in the field of Germinal center brings together such families of science as Molecular biology, Diffuse large B-cell lymphoma, Antigen and Virology.
His Pathology research is multidisciplinary, incorporating elements of Cancer, Large cell and B cell.
His Internal medicine research incorporates elements of Gastroenterology, Surgery and Oncology.
His Cancer research study combines topics from a wide range of disciplines, such as Gene expression profiling, Mutation, Anaplastic lymphoma kinase, Anaplastic large-cell lymphoma and Leukemia.
His most cited work include:
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms (3041 citations)
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. (1270 citations)
- BRAF mutations in hairy-cell leukemia (749 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Pathology, Lymphoma, Internal medicine, Cancer research and Immunology.
Stefano Pileri combines subjects such as Immunophenotyping and B cell with his study of Pathology.
His Lymphoma research is multidisciplinary, incorporating perspectives in Peripheral T-cell lymphoma and T cell.
His Internal medicine research includes themes of Gastroenterology, Surgery and Oncology.
The various areas that Stefano Pileri examines in his Cancer research study include Mutation, Leukemia and Gene expression, Gene expression profiling.
Stefano Pileri interconnects Myeloid and Myeloid leukemia in the investigation of issues within Leukemia.
He most often published in these fields:
- Pathology (41.79%)
- Lymphoma (41.79%)
- Internal medicine (29.52%)
What were the highlights of his more recent work (between 2015-2021)?
- Lymphoma (41.79%)
- Internal medicine (29.52%)
- Cancer research (25.79%)
In recent papers he was focusing on the following fields of study:
Lymphoma, Internal medicine, Cancer research, Oncology and Pathology are his primary areas of study.
His work deals with themes such as Peripheral T-cell lymphoma, B cell and Gene expression profiling, which intersect with Lymphoma.
His studies link Surgery with Internal medicine.
Within one scientific family, Stefano Pileri focuses on topics pertaining to T cell under Cancer research, and may sometimes address concerns connected to T-cell lymphoma.
His biological study spans a wide range of topics, including Prospective cohort study, Chemotherapy, ABVD and CD8.
His research is interdisciplinary, bridging the disciplines of BCL6 and Pathology.
Between 2015 and 2021, his most popular works were:
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms (3041 citations)
- Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network (139 citations)
- Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi (63 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His main research concerns Internal medicine, Lymphoma, Oncology, Cancer research and Pathology.
In Internal medicine, Stefano Pileri works on issues like Surgery, which are connected to Hazard ratio.
His work in the fields of Lymphoma, such as Anaplastic large-cell lymphoma, intersects with other areas such as Diagnostic algorithms.
His Anaplastic large-cell lymphoma research focuses on Tumor marker and how it relates to Immunology.
Stefano Pileri has researched Cancer research in several fields, including Gene expression profiling, Venetoclax, Regulation of gene expression, Gene and CD20.
His Pathology research is multidisciplinary, incorporating perspectives in BCL6, B cell, Hematopathology and Follicular dendritic cells.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
